CClinicalTrials.gg
Not yet recruitingNCT07660887Updated Jun 22, 2026

Olfactory Dysfunction in Aging Adults

An observational study in Olfactory Dysfunction, sponsored by Medical University of South Carolina. Not yet recruiting at 1 site in United States. Open to participants aged 50 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-22.

Sponsored by Medical University of South Carolina · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
500
Ages
50 Years and older
Sex
All
01

Study summary

This prospective longitudinal cohort study will enroll adults aged 50 years and older to characterize olfactory dysfunction in aging. Participants will undergo comprehensive olfactory testing, cognitive assessment, biomarker collection, and imaging to identify clinically relevant phenotypes based on anatomic site of dysfunction. The study will also evaluate the impact of olfactory dysfunction on quality of life and identify baseline factors associated with changes in olfactory function over time.

Read the detailed description

Olfactory dysfunction is common in older adults and is associated with impaired quality of life and increased mortality, yet underlying mechanisms and clinically relevant classifications remain poorly defined. Prior studies have relied on limited screening methods and have not adequately characterized the anatomic sites or mechanisms contributing to olfactory loss.

This prospective longitudinal cohort study will enroll adults aged 50 years and older to comprehensively evaluate olfactory function and its determinants. Participants will undergo psychophysical olfactory testing using Sniffin' Sticks (threshold, discrimination, and identification), cognitive assessment, nasal endoscopy, and olfactory mucus collection for biomarker analysis. A subset of participants will also undergo magnetic resonance imaging to assess peripheral and central olfactory structures.

The primary objective is to establish clinically relevant phenotypes of olfactory dysfunction based on olfactory testing and cognitive function, corresponding to peripheral, sensorineural, or central mechanisms. Secondary objectives are to determine the impact of olfactory dysfunction on quality of life, depression, social isolation, and nutrition using validated patient-reported outcome measures, and to identify baseline factors that predict longitudinal changes in olfactory function.

Participants will be followed annually with repeat olfactory testing and outcome assessments to evaluate changes over time and identify predictors of olfactory decline. This study aims to improve understanding of olfactory dysfunction in aging and provide a foundation for future diagnostic and therapeutic strategies.

02

Conditions studied

  • Olfactory Dysfunction
03

In context

Lead sponsor

Medical University of South Carolina is the lead sponsor of 852 studies on the registry; 165 are open to participants now.

Of its 128 completed or terminated interventional studies of FDA-regulated products, 101 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Community-dwelling adults aged 50 years and older recruited from the Medical University of South Carolina (MUSC) and surrounding community, including clinic patients and individuals responding to advertisements, who may have normal olfactory function or varying degrees of olfactory dysfunction.

Inclusion criteria

  • Age: 50 years or older
  • Ability to follow instructions and understand consent process in English
  • Adequate visual, auditory, or motor functioning to complete items in the test battery or availability of assistance or assist devices to complete tasks

Exclusion criteria

Exclusion Criteria:

- Vulnerable populations including prisoners or institutionalized individuals

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
500 participants (estimated)
Patient registry
No

Groups and cohorts

  • Older Adults With and Without Olfactory Dysfunction

    Adults aged 50 years and older enrolled in a prospective cohort study assessing olfactory function, cognition, biomarkers, and quality of life, with annual follow-up. Participants will be classified post hoc into olfactory phenotypes based on testing results.

    Other: Clinical and Biomarker Assessments

Interventions

  • OtherClinical and Biomarker Assessments

    Participants undergo olfactory testing (Sniffin' Sticks), cognitive assessment, nasal endoscopy, olfactory mucus collection, MRI imaging (subset), and patient-reported outcome measures to evaluate olfactory function, biomarkers, and health outcomes over time.

06

What researchers measure

Primary outcomes

  1. Olfactory Function

    Olfactory Threshold, Discrimination, and Identification (TDI scores) using Sniffin' Sticks.

    Time frame: Baseline

Secondary outcomes

  1. Change in Olfactory Function Over Time

    Longitudinal assessment of changes in olfactory function to identify decline over time.. Change in TDI scores (threshold, discrimination, identification)

    Time frame: Year 1 and year 2

  2. Patient-Reported Outcomes

    Patient-reported measure assessing quality of life using QOD questionnaire.

    Time frame: Baseline, Year 1 and year 2

07

Study locations

1 site
  • MUSC
    Charleston, South Carolina 29425, United States
08

References and documents

Publications

  • Soler ZM, Gregoski MJ, Kohli P, LaPointe KA, Schlosser RJ. Development and validation of the four-item Concise Aging adults Smell Test to screen for olfactory dysfunction in older adults. Int Forum Allergy Rhinol. 2025 Mar;15(3):250-257. doi: 10.1002/alr.23476. Epub 2024 Oct 27. PubMed 39462307 ↗

Individual participant data

Plan to share: No — Protection of individual privacy

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07660887
Lead sponsor
Medical University of South Carolina
Collaborators
National Institute on Deafness and Other Communication Disorders (NIDCD)
Responsible party
Sponsor
First posted
Jun 22, 2026
Start date
Apr 1, 2027 (estimated)
Primary completion
Apr 30, 2032 (estimated)
Completion
Apr 30, 2032 (estimated)
Last update
Jun 22, 2026

Study contacts

Rodney Schlosser, MD
Contact
schlossr@musc.edu
18437927165

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion